top of page

CGTI ATTENDEES

Paolo Martini, Previous CSO of Moderna speaking at The 8th Annual Cell & Gene Therapy Innovation Summit #CGTI which is taking place in the Hyatt Regency Barelona Tower, Spain on the 10th & 11th of September 2025
CGTI green logo.
For the patients, we must do better.

8th Annual Cell & Gene Therapy Innovation Leaders Summit 2025

10th & 11th September 2025
Hyatt Regency Barcelona Tower, Spain

The 8th Annual Cell and Gene Therapy Innovation Summit

The 8th Annual Cell and Gene Therapy Innovation Leaders Summit 2025: Scaling Impact, Accelerating Access

Join 200 top-tier C-suite executives at The Annual Cell and Gene Therapy Innovation Leaders Summit, an exclusive leadership summit designed to address the most pressing challenges facing the cell and gene therapy (CGT) sector.

 

As the field matures, the need for strategic, scalable solutions has never been more urgent. This high-level gathering offers a unique platform to collaborate, innovate, and lead the transformation of CGT from niche breakthroughs to mainstream therapies.

Across two dynamic days of curated keynotes, executive panels, and closed-door roundtables, we’ll tackle the barriers that stand between scientific progress and patient access:

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF
#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF
Learn more

Confirmed Speakers

Learn more

Register Interest

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF
Learn more

Programme

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

Uwe Gottschalk

Uwe Gottschalk is Operating Partner at Keensight Capital - Former CSO of Lonza

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

Jesse McCool

CSO of Bionova Scientific

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

Thomas Potgieter

SVP of Global Cell Therapy Development & Operations at Bristol Myers Squibb

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

Angela Vollstedt, PhD MBA

Director Global Cell & Gene Therapies Portfolio Management at Novartis

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

Paolo Martini

Chief Research & Development Officer at ReAlta Life Sciences former CSO at Moderna

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

Gwendolyn Binder PhD

President, Science and Technology at Cabaletta Bio

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

Warner Biddle

CEO at Kyverna Therapeutics former interim CEO at Kite a Gilead Company

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

Jens Vogel

Jens H. Vogel
President & COO of Mirai Bio - Former CEO of BI Fremont & Global Head of Biotech at Bayer Pharmaceuticals

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

2025 Programme Snapshot

Why It Matters: For the patients, we must do better.

Behind every scientific milestone and logistical breakthrough is a patient waiting often urgently -for life-changing treatment. This summit is not just about overcoming industry barriers; it’s about accelerating the timeline between discovery and delivery. By addressing these challenges at the highest level, we’re advancing a future where CGTs are not just available to a few, but accessible to many.

Whether it's a child with spinal muscular atrophy or an adult with aggressive leukemia, the decisions made in boardrooms today will shape outcomes in clinics tomorrow. Let’s ensure those decisions are bold, collaborative, and future-focused.

Picture at The 8th Annual Cell & Gene Therapy Innovation Summit #CGTI which is taking place in the Hyatt Regency Barelona Tower, Spain on the 10th & 11th of September 2025

KEY TOPICS

  • ​Digitalisation in CGT

  • Manufacturing Bottlenecks & Scalability

  • Regulatory Navigation & Quality Assurance

  • Supply Chain Transformation:

  • Investment & Commercialisation Strategy

  • Accelerate time to market and global regulatory alignment

  • Improve discovery & development timelines

#GBXevents

VENDOR FOCUS

  • Integration of (ML) (AI) in therapy development

  • Process automation and advanced analytics

  • Enable scalable, GMP-compliant production, reducing human error

  • Ensure seamless chain-of-identity and patient scheduling

  • Protect sensitive therapies in transit

  • Batch control and compliance

  • Enable audit readiness & traceability

#GBXevents

CORE PURPOSE

​Behind every therapy, every platform, and every breakthrough — there are people. The patients we fight for. The scientists, clinicians, and leaders who make it possible. The supply chain heroes, the nurses delivering cell infusions, and the parents holding on to hope.
The Annual Cell and Gene Therapy Innovation Leaders Summit is more than a leadership gathering.
It’s a platform to share the stories, surface the struggles, and accelerate the solutions that actually reach patients — not just pipelines.

​SPEAKERS 2025

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

"It's not the destination, it's the journey."

No events at the moment

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

WHY ATTEND

Exploring opportunities for small-scale CDMOs

Insights into key pain points such as shortage of talent and rising costs of supply chain

A deep dive into emerging biopharma pipelines and innovative emerging technologies

New innovations and strategies driving costs down and improving the manufacturing process

The promises and challenges of new therapeutic modalities  

Leveraging innovation to bridge the gap from Gene to GMP

Executive training for commercial innovation and how to make a profitable growth

Navigating pricing, market access and reimbursement framework

Regulatory updates and compliance

Novartis  speaking at The 8th Annual Cell & Gene Therapy Innovation Summit #CGTI #GBXevents
#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF
#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

WHO ATTENDS

  • Big Pharma - De-risk pipelines, accelerate new indications

  • Biotech - Build pipeline fast, increase valuation, get to IND

  • Academia - Publish, patent, or license new targets

  • Nonprofit/Government - Solve unmet needs, global health, outbreak response

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

WHY ATTEND

  • In-person only

  • Closed door

  • Boutique 

  • Pre-qualified and invited audience

  • Curated meetings

  • Fireside chats

  • Networking dinner

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

IN PERSON ONLY

  • CSO / CTO

  • CEO / COO (Startups)

  • VP of Cell Therapy Manufacturing    

  • Head of Personalised Therapy Ops

  • Director of Engineering    

  • R&D Leadership

  • Head of AI / Computational Biology    

  • Director of Translational Medicine

  • Head of Business Development  

  • VP of Manufacturing Strategy

  • CDMO Alliance Manager

warner_biddle_

INVITE ONLY LEADERS SUMMIT 

Benchmark with up to 200 decision makers in person only

SUMMIT INSIGHTS

200+

Up to 200 decision-makers in person. Previous attendee demographics include 50% EMEA, 30% America and 20% ROW

20%

20% best-of-breed vendors providing solutions to combat the manufacturing, scale-up & R&D hurdles of today's C&GT

06

Journey of CXO presentations. Six insightful, powerful and inspirational talks from CXOs in the industry

02

Exclusive in-person networking, over 2 days in Barcelona, on the 10th and 11th of September 

7+

Pre-scheduled and pre-qualified one-to-one meetings with delegates who influence or make a decision

90%

Over 90% of our attendance provided positive feedback. Please click here to see what our delegation has to say

PREVIOUS SPEAKERS

Uwe

Uwe Gottschalk

Operating Partner at Keensight Capital

ADVISORY

“Our very survival depends on our ability to stay awake, to adjust to new ideas, to remain vigilant and to face the challenge of change.” – Martin Luther King ...

Fausto Artico, Global R&D Tech Head and Product Director of Innovation and Data Science at GlaxoSmithKline is an advisor of The 7th Annual Cell & Gene Therapy Innovation Summit #CGTI 2024 which is being held in Barcelona, Spain on the 7th & 8th February 2023

Fausto Artico

Global R&D Tech Head and Product Director of Innovation and Data

Science at GlaxoSmithKline

Dorothee Ambrosius, Head of CMC Strategy Biologicals at Boehringer Ingelheim is an advisor of The 7th Annual Cell & Gene Therapy Innovation Summit #CGTI 2024 which is being held in Barcelona, Spain on the 7th & 8th February 2023

Dorothee Ambrosius

Head of CMC Strategy Biologicals at Boehringer Ingelheim

Jens H. Vogel, SVP & Global Head of Biotech at Bayeris an advisor of The 7th Annual Cell & Gene Therapy Innovation Summit #CGTI 2024 which is being held in Barcelona, Spain on the 7th & 8th February 2023

Jens H. Vogel

SVP and Global Head of Biotech at Bayer Pharmaceuticals

Jesse McCool, Co-Founder & CEO of Wheeler Bio is an advisor of The 7th Annual Cell & Gene Therapy Innovation Summit #CGTI 2024 which is being held in Barcelona, Spain on the 7th & 8th February 2024

Jesse McCool

Co-Founder and CEO at Wheeler Bio

#GBXEVENTS 2024 #CGTI #BILS #MEVO #DDIF

LEADERS SHAPING THE FUTURE

ADVISORY

“For the patients, we must do better."

bottom of page